Performance Assessment of the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method for Rapid Detection of Susceptibility to Ethambutol and Molecular Prediction of Extensively Drug-resistant Tuberculosis in Clinical Isolates of M - Wikidata - awgldk - TriplyDB

Performance Assessment of the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method for Rapid Detection of Susceptibility to Ethambutol and Molecular Prediction of Extensively Drug-resistant Tuberculosis in Clinical Isolates of M

Performance Assessment of the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method for Rapid Detection of Susceptibility to Ethambutol and Molecular Prediction of Extensively Drug-resistant Tuberculosis in Clinical Isolates of M

http://www.wikidata.org/entity/Q37007631

about

Transmission Electron Microscopy of XDR Mycobacterium tuberculosis Isolates Grown on High Dose of Oﬂoxacin

P2860

Q36268998-FDBC1007-E506-4DBE-87DA-0478B1F2367C

P2860

Performance Assessment of the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method for Rapid Detection of Susceptibility to Ethambutol and Molecular Prediction of Extensively Drug-resistant Tuberculosis in Clinical Isolates of M

http://www.wikidata.org/entity/Q37007631

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 June 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Performance Assessment of the ...... osis in Clinical Isolates of M

@en

Performance Assessment of the ...... osis in Clinical Isolates of M

@nl

type

label

Performance Assessment of the ...... osis in Clinical Isolates of M

@en

Performance Assessment of the ...... osis in Clinical Isolates of M

@nl

prefLabel

Performance Assessment of the ...... osis in Clinical Isolates of M

@en

Performance Assessment of the ...... osis in Clinical Isolates of M

@nl

P1433

Q37007631-BC77B472-5ED0-4E4C-99AD-1A66569E9D15

P1476

Q37007631-0470E819-36C5-417D-8450-5568C61DDEBF

P2093

Q37007631-0AF4780E-FA60-4308-AE9F-BCBC4C366202

Q37007631-677BFF92-74D3-46EA-8B77-99D90D75BD7A

Q37007631-6F1FB921-3D34-4960-80DB-57B949AEC76A

Q37007631-857D175A-CFB1-48F9-A542-93C7977955ED

Q37007631-B6215407-C085-4AED-9725-2873B72261E7

Q37007631-DE2A8086-F5D5-4CAE-9CDC-005B7B3DE929

Q37007631-EB3127C7-DD3D-4D03-8597-6A95319C387A

P2860

Q37007631-0D7CE4C7-8827-45D5-AECB-BDF80FA423A2

Q37007631-25C117D6-DBEA-4DD1-AB1C-54B1055FCC32

Q37007631-27EF0876-998E-4025-AD54-1DC63FC303C6

Q37007631-341B4B56-A8B2-40A4-A93C-7444B15A8CDD

Q37007631-378BBA1F-3D26-4911-9CA5-3B54A4047035

Q37007631-3F8902D3-35C4-4D07-8FA2-F37302C80141

Q37007631-43CE3ABA-AAB1-452D-89AF-CD751BC83288

Q37007631-63B30E05-7476-4559-B852-3EA9DD677180

Q37007631-6E213DDD-9880-4D60-87B3-38C135F721F4

Q37007631-7BAF69C7-F1E2-4D9F-A856-D81B25FB76B0

P304

Q37007631-54ECB91D-8EA2-407B-BB2A-CC2890DCE66C

P31

Q37007631-5E25C9C1-6820-4D8C-80BE-7C42AE692ED4

P356

Q37007631-2552430C-C8D8-4007-B988-6D21B2B78EA1

P433

Q37007631-2A967004-30BC-4077-92C1-D9DA92030D59

P478

Q37007631-D83495F2-D8AB-4BA9-A895-6E66395DEF29

P50

Q37007631-3D1BDA55-F74A-4013-8120-BBE834AA6F56

P577

Q37007631-365FD1AE-947C-4B35-A9DD-A11195F994C8

P5875

Q37007631-4FF31B8D-52DA-4A05-ACAB-19E3138AEDAD

P698

Q37007631-DE4566B6-189D-4591-A6B2-F49FC381CD9D

P921

Q37007631-6DEBE5D0-6173-4488-BA73-488241A1EA43

P932

Q37007631-D1D29D11-9F33-4EA8-994B-30CC6664F987

P356

P1433

West Indian Medical Journal

P1476

Performance Assessment of the ...... osis in Clinical Isolates of M

@en

P2093

L P Titov

http://www.w3.org/2001/XMLSchema#string

M Arjomandzadegan

http://www.w3.org/2001/XMLSchema#string

M R Zolfaghari

http://www.w3.org/2001/XMLSchema#string

M Sadrnia

http://www.w3.org/2001/XMLSchema#string

M Shojapoor

http://www.w3.org/2001/XMLSchema#string

M Taherahmadi

http://www.w3.org/2001/XMLSchema#string

R Nazari

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance

Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis

Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates.

Global tuberculosis incidence and mortality during 1990-2000.

Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis

Five-antituberculosis Drug-resistance Genes Detection Using Array System

Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.

P304

325-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7727/WIMJ.2014.022

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281481811

http://www.w3.org/2001/XMLSchema#string

P698

26624582

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

4909062

http://www.w3.org/2001/XMLSchema#string